| Pfizer Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500680 |
NSE Symbol : PFIZER |
P/E(TTM) : 22.72 |
|
ISIN Demat : INE182A01018 |
Div & Yield% : 1.96 |
EPS(TTM) : 168.11 |
|
Book Value(₹) : 918.71 |
Market Cap(₹Cr) : 17,475.40 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,519.65 | 2,281.35 | 2,193.17 | 2,424.76 | 2,610.99 |
| Other Income | 187.95 | 345.06 | 188.46 | 134.05 | 62.65 |
| Stock Adjustments | 33.59 | -25.36 | 11.82 | -56.48 | 72.90 |
| Total Income | 2,741.19 | 2,601.05 | 2,393.45 | 2,502.33 | 2,746.54 |
| EXPENDITURE : | |||||
| Raw Materials | 917.90 | 785.09 | 804.39 | 817.19 | 1,020.93 |
| Power and Fuel Cost | 3.20 | 3.48 | 3.98 | 6.51 | 5.67 |
| Other Manufacturing Expenses | 58.01 | 50.54 | 51.17 | 51.63 | 59.81 |
| Selling and Administration Expenses | 259.96 | 260.05 | 317.96 | 298.03 | 310.77 |
| Miscellaneous Expenses | 91.18 | 45.18 | 44.37 | 54.29 | 47.10 |
| Employee Benefit Expenses | 367.97 | 371.33 | 347.80 | 331.68 | 403.67 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,042.97 | 1,085.38 | 823.78 | 943.00 | 898.59 |
| Interest | 9.57 | 8.50 | 15.43 | 13.48 | 10.70 |
| Gross Profit | 1,033.40 | 1,076.88 | 808.35 | 929.52 | 887.89 |
| Depreciation | 57.73 | 60.79 | 62.28 | 105.51 | 115.00 |
| Profit Before Tax | 975.67 | 1,016.09 | 746.07 | 824.01 | 772.89 |
| Current Tax | 257.52 | 264.10 | 158.63 | 251.99 | 196.26 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -4.28 | -15.61 | 36.11 | -51.91 | -35.93 |
| Reported Net Profit | 722.43 | 767.60 | 551.33 | 623.93 | 612.56 |
| Extraordinary Items | -36.25 | 215.80 | 3.62 | 22.95 | 1.13 |
| Adjusted Net Profit | 758.68 | 551.80 | 547.71 | 600.98 | 611.43 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 2,435.86 | 1,828.39 | 1,460.05 | 1,133.47 | 681.03 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 754.84 | 160.13 | 182.99 | 297.35 | 160.12 |
| P & L Balance carried down | 2,403.45 | 2,435.86 | 1,828.39 | 1,460.05 | 1,133.47 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 750.00 | 1,650.00 | 350.00 | 400.00 | 350.00 |
| Dividend Per Share(Rs) | 75.00 | 165.00 | 35.00 | 40.00 | 35.00 |
| Earnings Per Share-Unit Curr | 157.91 | 167.78 | 120.51 | 136.38 | 133.89 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 918.67 | 921.84 | 785.91 | 701.05 | 626.10 |
| Book Value(Adj)-Unit Curr | 918.67 | 921.84 | 785.91 | 701.05 | 626.10 |
